The global artificial lung market size was valued at USD 2.63 billion in 2025 and is projected to grow from USD 2.91 billion in 2026 to USD 6.52 billion by 2034, registering a CAGR of 10.61% during the forecast period from 2026 to 2034. North America dominated the artificial lung market with a market share of 39.2% in 2025.
An artificial lung is a medical device designed to temporarily perform the gas exchange function of the lungs by adding oxygen to the blood and removing carbon dioxide. It is commonly used in critical care settings, particularly during extracorporeal membrane oxygenation (ECMO) and certain cardiac or pulmonary surgeries. Artificial lungs provide life-saving respiratory support for patients with severe heart or lung failure while their organs recover or until transplantation is possible.
Download a Free Sample To learn more about this report,
Growing Development of Next-Generation Artificial Lung Systems for Bridge-to-Transplant Care
The artificial lung market is advancing as researchers and medical device developers focus on next-generation systems that can temporarily replace lung function in patients with severe respiratory failure. Unlike conventional extracorporeal membrane oxygenation (ECMO), newer artificial lung technologies are designed to provide more stable blood circulation, improve oxygen delivery, and support patients for longer periods before lung transplantation. These innovations are contributing to the artificial lung market size as healthcare providers seek advanced life-support technologies that improve survival rates and expand treatment options for critically ill patients.
Increasing Clinical Adoption of Portable Artificial Lung Technologies
Another important trend shaping the market is the growing development of portable artificial lung systems that enable easier deployment in intensive care units and transplant centers. Manufacturers are focusing on compact, user-friendly devices that improve patient mobility, simplify clinical workflows, and provide effective respiratory support during complex cardiothoracic procedures. This innovation is supporting artificial lung market growth by expanding the clinical use of advanced extracorporeal life-support technologies across hospitals and specialized care centers.
Rising Incidence of Respiratory Diseases and Growing Adoption of ECMO Therapy
The artificial lung market is experiencing steady growth due to the increasing prevalence of severe respiratory disorders such as acute respiratory distress syndrome (ARDS), chronic obstructive pulmonary disease (COPD), pulmonary fibrosis, and respiratory failure. Artificial lung systems, particularly extracorporeal membrane oxygenation (ECMO) devices, are increasingly used to provide life-saving respiratory support for critically ill patients awaiting recovery or lung transplantation. Growing investments in critical care infrastructure and advancements in extracorporeal life support technologies are further encouraging adoption. These developments continue to strengthen artificial lung market demand across hospitals and specialized intensive care units.
High Treatment Costs and Limited Availability of Specialized Care
The artificial lung market faces restraints due to the high cost of ECMO systems, disposable circuits, oxygenators, and specialized intensive care required during treatment. Successful use of artificial lung technology also depends on highly trained multidisciplinary teams and advanced hospital infrastructure, limiting accessibility in many developing regions. In addition, reimbursement challenges and ongoing maintenance expenses further increase the financial burden on healthcare providers. These factors continue to influence the overall artificial lung market analysis, particularly in resource-constrained healthcare systems.
Advancements in Portable Artificial Lung Technologies and Long-Term Respiratory Support
The artificial lung market presents significant opportunities as researchers and medical device manufacturers continue developing compact, portable, and wearable artificial lung systems for extended respiratory support. Improvements in membrane oxygenators, biocompatible materials, and miniaturized pump technologies are expected to enhance patient mobility and expand treatment beyond traditional intensive care settings. Growing investments in next-generation extracorporeal life support systems and bridge-to-transplant technologies are also creating new opportunities. These developments continue to support positive artificial lung market trends across critical care medicine.
Maintaining Long-Term Biocompatibility and Reducing Device-Related Complications
The artificial lung market continues to face challenges in improving long-term device performance while minimizing complications such as blood clot formation, bleeding, infection, and inflammatory responses. Manufacturers must develop highly biocompatible materials, optimize blood flow dynamics, and improve membrane durability to extend treatment duration safely. Continuous innovation is also required to reduce system complexity while maintaining reliable gas exchange performance. Successfully addressing these challenges will remain essential for strengthening the future artificial lung market report.
Extracorporeal Membrane Oxygenation (ECMO) Systems Segment Dominated the Market with 40.8% Share in 2025
The extracorporeal membrane oxygenation (ECMO) systems segment dominated the global artificial lung market with a 40.8% market share in 2025, valued at USD 1.07 billion. The segment's dominance is driven by the widespread use of ECMO systems for managing severe respiratory and cardiac failure, increasing demand for advanced life-support technologies, and their proven effectiveness in critical care settings.
The paracorporeal artificial lungs, intracorporeal artificial lungs, membrane oxygenators, and portable artificial lungs segments continue to witness steady growth due to ongoing technological advancements, increasing research in long-term respiratory support, and rising demand for compact and patient-friendly respiratory care solutions.
Request Customizationto receive a tailored report.
The Long-Term Support for Chronic Lung Diseases Segment is Projected to Register the Fastest Growth at a CAGR of 10.7%
The long-term support for chronic lung diseases segment is projected to register the fastest growth at a CAGR of 10.7% during the forecast period. The rising prevalence of chronic respiratory disorders, increasing demand for long-term respiratory assistance, and continuous advancements in artificial lung technologies are driving growth in this segment.
The bridge-to-transplantation, bridge-to-recovery, ECMO-assisted ventilation, and pulmonary rehabilitation segments continue to play a crucial role in respiratory care by providing temporary life support, improving patient outcomes, and supporting recovery before or after lung transplantation. Expanding clinical adoption and advancements in critical care technologies continue to strengthen these applications.
Tertiary Care Hospitals Segment Dominated the Market with 48.7% Share in 2025
The tertiary care hospitals segment dominated the global artificial lung market with a 48.7% market share in 2025, valued at USD 1.28 billion. The segment's leadership is attributed to the availability of advanced intensive care infrastructure, highly specialized healthcare professionals, and increasing utilization of ECMO and artificial lung systems for managing critically ill patients.
The transplant centers, research institutions and clinical trial sites, and specialty respiratory clinics continue to experience steady growth as investments in organ transplantation, respiratory disease research, and specialized pulmonary care expand. Growing clinical research activities and technological innovations are further supporting the adoption of artificial lung technologies across these healthcare settings.
Speak to an Analystto discuss market opportunities.
North America's artificial lung market accounted for 39.2% of the global market, reaching USD 1.03 billion in 2025, and is projected to grow at a CAGR of 8.1% during the forecast period. Market growth is driven by the rising prevalence of chronic respiratory diseases, increasing adoption of extracorporeal membrane oxygenation (ECMO) systems, expanding healthcare infrastructure, and continuous advancements in artificial organ technologies.
The United States is the largest contributor to the North American market. Increasing incidence of respiratory disorders, growing demand for advanced critical care devices, expanding adoption of ECMO systems, and rising investments in healthcare innovation continue to drive market growth.
Growing healthcare investments, increasing awareness of advanced respiratory care technologies, expanding access to critical care services, and rising adoption of artificial lung support systems continue to support steady market expansion.
Unlock Regional Insightsto access country-level data, & regional trends.
The European artificial lung market accounted for 27.1% of the global market, reaching USD 0.71 billion in 2025, and is expected to register a CAGR of 7.8% during the forecast period. Increasing prevalence of respiratory diseases, expanding healthcare infrastructure, growing investments in medical technologies, and rising adoption of advanced life support systems continue to support regional market growth.
Strong healthcare infrastructure, increasing adoption of advanced respiratory support devices, expanding investments in medical technology innovation, and growing demand for critical care solutions continue to support market growth.
Growing investments in intensive care facilities, increasing awareness of respiratory disease management, expanding use of ECMO technologies, and rising demand for advanced life support equipment continue to strengthen market demand.
The Asia Pacific artificial lung market accounted for 22.4% of the global market, reaching USD 0.59 billion in 2025, and is projected to register a CAGR of 10.6% during the forecast period. Rapid healthcare infrastructure development, increasing prevalence of chronic respiratory diseases, rising healthcare expenditure, growing access to advanced critical care services, and expanding adoption of life-support technologies continue to accelerate regional market growth.
China represents the largest share within the Asia Pacific market. Expanding healthcare infrastructure, increasing investments in critical care technologies, growing incidence of respiratory diseases, and strong government support for healthcare modernization continue to drive market expansion.
A growing aging population, increasing adoption of advanced respiratory care technologies, expanding healthcare investments, and rising demand for innovative life-support systems continue to support market growth.
The Middle East & Africa artificial lung market accounted for 5.0% of the global market, reaching USD 0.13 billion in 2025, and is anticipated to grow at a CAGR of 8.4% during the forecast period. Increasing investments in healthcare infrastructure, expanding access to advanced critical care technologies, growing awareness of respiratory disease management, and rising demand for life-support equipment continue to support regional expansion.
Government investments in healthcare modernization, expanding critical care facilities, increasing adoption of advanced respiratory support systems, and rising demand for innovative medical technologies continue to drive market growth.
Growing healthcare infrastructure, increasing access to critical care services, expanding adoption of advanced respiratory support technologies, and rising investments in medical equipment continue to support steady market expansion.
Customize This Report to Match Your Strategic Objectives
Author's Details
Healthcare Lead
Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, competitive dynamics, and market opportunities. Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.
Her work focuses on assessing treatment landscapes, outsourcing models, technology adoption, market access dynamics, regulatory developments, and competitive positioning across healthcare and life sciences industries. Debashree has consistently supported organizations in understanding market gaps, evaluating revenue potential, developing market entry strategies, and shaping expansion plans across complex and fast evolving healthcare markets.
With a strong analytical foundation and structured research approach, she excels at synthesizing large datasets, stakeholder inputs, and market signals into actionable insights that guide strategic decision making. Her healthcare expertise enables her to connect clinical, commercial, and operational developments with business opportunities, helping stakeholders anticipate shifts and capitalize on emerging growth areas. Debashree’s consulting oriented mindset and deep healthcare industry understanding make her a trusted advisor to businesses navigating dynamic and rapidly evolving healthcare markets.
Assisted Walking Devices Market Size, Share, Growth, 2034
Spirometer Market Size, Share, Growth, Analysis, Report, 2034
Vessel Sealing Devices Market Size, Share, Growth, Analysis, 2034
ECG Patch and Holter Monitor Market Size, Share, Growth, 2034
Tampon Market Size, Share, Growth, Opportunities, Analysis, 2034
Artificial Cornea and Corneal Implant Market Size, Share, 2034
We are featured on:
sales@straitsresearch.com